Trump Team Outlines Healthcare Agenda—No Mention of Drug Prices
Xconomy
NOVEMBER 10, 2016
There is no mention of drug pricing or what the administration might do about frequent price increases, such as Mylan’s EpiPen practice, that critics say are unsubstantiated and unethical. The incoming Trump administration has posted an outline of its healthcare agenda on its transition website.
Let's personalize your content